Robert Cyran

Hubris therapy

Bristol-Myers suffers $21 bn self-inflicted wound

It's a marathon

Sprint to face challenges after SoftBank deal

Look on my work

Nokia phone demise a warning for all tech giants

Warren Appleseed

Apple falls far from Buffett's investing tree

Rosebud

Facebook better off liking title of top media firm

Know your strengths

Activist + private equity = no M&A for Symantec

Magical feast

Capital drought will spark 'Unicorn' M&A orgy

Location, location, location

Even Facebook can't make distance disappear

Pfizzling benefits

Pfizer's $150 bn plan is high-risk, low-benefit

Walk the walk

Twitter CEO's creative giveback is promising start

Gracefully maturing

Google and Amazon grapple happily with maturity

Join the club

Elon Musk whistles past Tesla's graveyard

One wing and a prayer

New Twitter CEO flaps with one wing behind back

Xi whiz

Xi Jinping parades Silicon Valley's tech hostages

Donor card

Asset-stripping Yahoo could mean profitable relief

Fantasy valley

Tech's real China syndrome victims are yet to fall

Don't drink and pink

'Female Viagra' maker seems to have convinced FDA by dint of a PR drive

Short-term pain

Wal-Mart's 'investment' in wages may pay off

For the birds

Twitter's mealy-mouthed strategy is hard to follow

Time out

Apple has time on its side